KEY TAKEAWAY: Some pharma company CEO’s are living in a bubble and don’t understand why consumers are angry at the pharma industry. Despite the fact that some cancer patients, for example, are living longer US consumers are sick of paying more for healthcare and prescription drugs. Continue reading
KEY SUMMARY: Fobres, in a recent editorial, said “Pharma Needs A Leader In 2016” and I couldn’t agree more, but let’s be honest here, most pharma CEO’s are NOT leaders but rather high paid executives who bow to investor needs and demands. Continue reading
KEY TAKEAWAY: When shareholders are prioritized patients usually find themselves on the short end of the stick. Can the two ever live together?